Clinical Trial Update: Biomechanical and Electrophysiological Effects of Duloxetine in the Treatment of Women With Urinary Stress Incontinence [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the biomechanical and electrophysiological effects of duloxetine in women with urinary stress incontinence has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urinary Incontinence
• Urinary Stress Incontinence

Drugs mentioned

• Duloxetine (DULOXETINE)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Urinary Stress Incontinence | Phase 3 | Status: COMPLETED